Join the live Q&A on PrEP, the latest in HIV prevention. Text your questions to 713-526-1111 and tune in Monday to learn ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.
The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children's Home in ...
According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...
Researchers at the University of Toronto found that HIV transmission risks were higher during droughts and other extreme ...
Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments.
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
When transitioning from prison to the community, formerly incarcerated individuals face numerous challenges, including lack ...
At the State of Black Health second annual summit hosted by BlackDoctor.org in partnership with USA TODAY, corporate leaders ...